Trilogy Capital’s Fabrinet FN Stock Holding History

Trilogy Capital’s Portfolio FN Stock Details FN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-320	Closed	-$15K	–	282
2018 Q3	$15K	Buy	320 +200	+167%	+$8.59K	﹤0.01%	292
2018 Q2	$4K	Buy	+120	New	+$4.11K	﹤0.01%	385

Other funds holding FN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

NPIC

Neumeier Poma Investment Counsel Carmel, California $1.21B AUM 70.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

Trilogy Capital's FN Position: Q4 2018 in Review

Trilogy Capital sold out of Fabrinet (FN) in Q4 2018, closing a stake of 320 shares — an estimated $15K sold.

Trilogy Capital first reported a position in FN in Q2 2018 and held it in 2 quarters. The position peaked at $15K in Q3 2018. 241 funds tracked by Wall St. Rank hold FN as of Q4 2018.

Trilogy Capital reported no remaining Fabrinet position as of Q4 2018 after selling out during the quarter.
Trilogy Capital sold 320 Fabrinet shares in Q4 2018, an estimated $15K.
Trilogy Capital first reported a position in Fabrinet in Q2 2018 and held it in 2 quarters.
Trilogy Capital's Fabrinet position peaked at $15K in Q3 2018.
241 funds tracked by Wall St. Rank held Fabrinet as of Q4 2018.

Based on Trilogy Capital's 13F filing for Q4 2018, filed 15 Jan 2019.